| |
Past and Current Student Papers Published or In Press - (program students
are marked in bold):
- Siemens D.R., Elzey B.D., Lubaroff D.M., Bohlken C., Jensen
R.J., Swanson A.K., and Ratliff T.L. (2001) Restoration of the ability
to generate CTL in mice immune to adenovirus by delivery of virus in
a collagen-based matrix. J. Immunol. 166:731-735.
- Lemke (Bohlken), C.D., Haynes, J.S., Spaete, R.,
Adolphson, D., Vorwald, A., Lager, K. and Butler, J.E. (2004) Lymphoid
hyperplasia resulting
in immune
dysregulation is caused by porcine reproductive and respiratory syndrome
virus infection in neonatal pigs. J. Immunol. 172: 1916-1925.
- Brown, K.D., Hostager, B.S. and Bishop, G.A. (2001) Differential
signaling and TRAF degradation mediated by CD40 and the EBV oncoprotein
LMP1. J. Exp. Med. 193:943-954.
- Brown, K.D., Hostager, B.S. and Bishop, G.A. (2002) Regulation
of TRAF2 signaling by self-induced degradation. J. Biol. Chem. 277:19433-19438.
- Bishop, G.A., Hostager, B.S. and Brown, K.D. (2002) Mechanisms
of tumor necrosis factor receptor associated factor (TRAF) regulation
in B lymphocytes. J. Leukoc. Biol. 72(1):19-23.
- Crowther, J.E., Kutala, V.K., Kuppusamy, P., Ferguson,
J.S., Beharka, A.A., Zweier, J.L., McCormack, F.X. and Schlesinger,
L.S.
(2004) Pulmonary
surfactant protein A inhibits macrophage reactive oxygen intermediate
production in response to stimuli by reducing NADPH oxidase activity.
J. Immunol., 172:6866-6874.
-
Dandekar, A.A., Anghelina, D., and Perlman, S. (2004) Bystander
T cell mediated demyelination is interferon-gamma dependent in a coronavirus
model of multiple sclerosis. Am. J. Pathol. 164:363-369.
- Dandekar, A.A. and Perlman, S. (2003) Axons and neurons in
coronavirus induced demyelination. In: Expermental models of multiple
sclerosis, E. Lavi, ed. (in press).
- Dandekar, A.A., Jacobsen, G., Waldschmidt, T.J., Perlman,
S. (2003) Antibody-mediated protection against cytotoxic T cell escape
in coronavirus-induced demyelination. J. Immunol, J. Virol. 77:11867-11874..
- Dandekar, A.A. and Perlman, S. (2002). Virus-induced demyelination
in nude mice is mediated by gamma-delta T cells. Am. J. Pathol. (4):1255-63.
- Wu, G., Dandekar, A., Pewe, L., and Perlman, S. (2000) CD4
and CD8 T cells have redundant but not identical roles in virus-induced
demyelination. J. Immunol. 165:2278-2286.
- Wu, G., Dandekar, A., Pewe, L., and Perlman, S. (2001) The
role of CD4 and CD8 T cells in MHV-JHM-induced demyelination. Adv. Expt.
Med. Biol., 494:341-7.
- Dandekar, A.,Wu, G., Pewe, L., and Perlman, S. (2001) Axonal
damage is T-cell mediated and occurs concomitantly with demyelination
in mice infected with neurotropic coronavirus. J. Virol. 75:6115-6120.
- Erickson, L.D., Tygrett, L.T., Bhatia, S.K., and Waldschmidt,
T.J. (1996) Differential expression of CD22 (Lyb8) on murine B cells.
Int. Immunol. 8:1121-1129.
- Erickson, L.D. and Waldschmidt, T.J. (1998) T helper cell activation
of B1 cells. Mucosal Immunology Update 6:10.
- Erickson, L.D., Foy T.M., and Waldschmidt, T.J. (2001) Murine
B1 B cells require IL-5 for optimal T cell-dependent activation. J.
Immunol.166:1531-1539.
- Fang, N., Motto, D.G., Ross, S.E., and Koretzky, G.A. (1996)
Tyrosines 113, 128, and 145 of SLP-76 are required for optimal augmentation
of NFAT promoter activity. J. Immunol. 157:3769-3773.
- Peterson, E.J., Clements, J.L., Fang, N. and Koretzky, G.A.
(1998) Adaptor proteins in lymphocyte antigen-receptor signaling. Curr.
Opin. Immunol. 10:337-344.
- Binstadt, B.A., Billadeau, D.D., Jevermovic, D., Williams, B.L., Fang,
N., Yi, T., Koretzky, G.A., Abraham, R.T. and Leibson, P.J. (1998)
SLP-76 is a direct substrate of SHP-1 recruited to killer cell inhibitory
receptors. J. Biol. Chem. 273: 27518-27523.
- Liu, S.K., Fang, N., Koretzky, G.A., and McGlade, C.J. (1999)
The hematopoietic-specific adaptor protein gads functions in T-cell
signaling via interactions with the SLP-76 and LAT adaptors. Current
Biology 9:67-75.
- Fang, N., and Koretzky, G.A. (1999) SLP-76 and Vav function
in separate, but overlapping pathways to augment interleukin-2 promoter
activity. J. Biol. Chem. 274(23):16206-16212.
- Gantt, K.R., Schultz-Cherry, S., Rodriguez, N., Jeronimo, S.M.,
Nascimento, E.T., Goldman, T.L., Recker, T.J., Miller, M.A., Wilson,
M.E. (2003) Activation of TGF-beta by Leishmania chagasi: importance
for parasite survival in macrophages. J Immunol. Mar 1;170(5):2613-20.
- Gantt, K.R., Goldman, T.L., McCormick, M.L., Miller, M.A.,
Jeronimo, S.M., Nascimento, E.T., Britigan, B.E., and Wilson, M.E. (2001)
Oxidative responses of human and murine macrophages during phagocytosis
of Leishmania chagasi. J. Immunol. 167(2):893-901.
- Miller, M.A., McGowan, S.E., Gantt, K.R., Champion, M., Novick,
S.L., Andersen, K.A., Bacchi,
C.J., Yarlett, N., Britigan, B.E., and Wilson, M.E. (2000) Inducible
resistance to oxidant stress in the protozoan Leishmania chagasi.
J.
Biol. Chem. 275(43):33883-33889.
- Hamilton. S.E., Porter, B.P., Messingham,
K.A.N., Badovinac, V.P. and Harty, J.T. (2004) Class Ia-restricted
memory T-cells inhibit expansion
of a non-protective class Ib-(H2-M3)-restricted memory response. Nat.
Immunol. 5:159-168.
- Tvinnereim, A. R., Kolwyck, D., Hamilton, S.E. and Harty, J.T.
(2004) Neutrophil involvement in cross-priming CD8+ T cell responses
to
bacterial antigens. Submitted.
- Badovinac, V.P., Hamilton, S.E. and Harty, J.T. (2003) Viral
infection results in massive CD8+ T cell expansion and mortality in
vaccinated perforin-deficient mice. Immunity. 18:463-474.
- Badovinac, V.P., Messingham, K.A.N., Hamilton, S.E. and Harty,
J.T. (2003) Regulation of CD8+ T cells undergoing primary and secondary
responses to infection in the same host. J. Immunol. 170:4933-4942.
- Tvinnereim, A.R., Hamilton, S.E., and Harty, J.T. (2002). CD8+
T cell response to secreted and non-secreted antigens delivered by recombinant
Listeria monocytogenes during secondary infection. Infect. Immun. 70:
153-162.
- Hamilton, S.E., and Harty, J.T. (2002). Quantitation of CD8(+)
T Cell Expansion, Memory, and Protective Immunity After Immunization
with Peptide-Coated Dendritic Cells. J. Immunol. 2002 169(9):4936-4944.
- Hamilton, S.E., Tvinnereim, A.R., and Harty, J.T. (2001) Listeria
monocytogenes Infection Overcomes the Requirement for CD40 Ligand in
Exogenous Antigen Presentation to CD8(+) T Cells. J Immunol. 15;167(10):5603-9.
- Grandea, A. G., III, Golovina, T. N., Hamilton, S. E., Sriram,
V., Spies, T., Brutkiewicz, R. R., Harty, J. T., Eisenlohr, L. C., and
Kaer, L. V. (2000) Impaired assembly yet normal trafficking of MHC class
I molecules in Tapasin mutant mice. Immunity 13:213-222.
- Haxhinasto, S.A., and Bishop, G.A. (2004) Synergistic B cell activation
by CD40 and the B cell antigen receptor: Role of BCR-mediated kinase
activation and TRAF regulation. J. Biol. Chem. 279:2575-2582.
- Haxhinasto, S.A., Bishop, G.A. (2003) Synergistic B cell activation
by CD40 and the B cell antigen receptor: Role of
BCR-mediated kinase activation and TRAF regulation. J. Biol. Chem., in press.
- Hostager, B.S., Haxhinasto, S.A., Rowland, S.L., Bishop, G.A. (2003)
Tumor necrosis factor receptor-associated factor 2 (TRAF2)-deficient
B lymphocytes
reveal novel roles for TRAF2 in CD40 signaling. J. Biol. Chem. 278:45382-45390.
- Haxhinasto, S.A. and Bishop, G.A. (2003) A novel interaction
between PKD and TRAF molecules regulates BCRCD40 synergy. J. Immunol.
171:4655-62.
- Bishop, G.A, Haxhinasto, S.A., Stunz, L.L., and Hostager,
B.S. (2003) Antigen-specific B lymphocyte activation. Crit. Rev. Immunol.
23:149-197.
- Haxhinasto, S.A., Hostager, B.S., Bishop, G.A. (2002) Cutting
edge: molecular mechanisms of synergy between CD40 and the B cell
antigen receptor: role for TNF receptor-associated factor 2 in receptor
interaction. J. Immunol. 169(3):1145-1149.
- Stunz, L.L., Lenert, P., Peckham, D., Yi, A.K., Haxhinasto, S.,
Chang, M., Krieg, A.M., Ashman, R.F. (2002) Inhibitory oligonucleotides
specifically block effects of stimulatory CpG oligonucleotides in
B cells. Eur. J. Immunol. 32(5):1212-1222.
- Hostager, B.S., Hsing, Y., Harms, D.E., and Bishop, G.A. (1996)
Different CD40-mediated signaling events require distinct CD40 structural
features. J. Immunol. 157:1047-1053.
- Hsing, Y., Hostager, B.S., and Bishop, G.A. (1997) Characterization
of CD40 signaling determinants regulating NF-kB activation in B lymphocytes.
J. Immunol. 159:4898-4906.
- Hsing, Y., and Bishop, G.A. (1999) Requirement for NF-kB activation
by a distinct subset of CD40-mediated effector functions in B lymphocytes.
J. Immunol. 162:2804-2811.
- Bishop, G.A., Hsing, Y., Hostager, B.S., Jalukar, S.V., Ramirez,
L. and Tomai, M.A. (2000) Molecular mechanisms of B lymphocyte activation
by the immune response modifier, R-848. J. Immunol. 165:5552-5557.
- Kusner, D.J., Hall, C.F. and Jackson, S. (1999) Fcg receptor-mediated
activation of phospholipase D regulates macrophage phagocytosis of IgG-opsonized
particles. J. Immunol. 162:2266-2274.
- Kemp, T.J., Kim, J.S., Crist, S.A., and Griffith, T.S. (2003) Induction
of necrotic tumor cell death by TRAIL/Apo-2L. Apoptosis. Dec;8(6):587-99.
- Kemp, T.J., Elzey, B.D., and Griffith, T.S. (2003) Plasmacytoid
dendritic cell-derived IFN-alpha induces TNF-related apoptosis-inducing
ligand/Apo-2L-mediated antitumor activity by human monocytes following
CpG oligodeoxynucleotide stimulation. J Immunol. Jul 1;171(1):212-8.
- Griffith, T.S., and Kemp, T.J. (2003) The topoisomerase I inhibitor
topotecan increases the sensitivity of prostate tumor cells to TRAIL/Apo-2L-induced
apoptosis. Cancer Chemother Pharmacol. Sep;52(3):175-84.
- Kemp, T.J., Moore, J., and Griffith, T.S. (2004)
Human B cells express functional TRAIL/Apo-2L after CpG ODN, J. Immunol.
July 15;173(2):892-899.
- Kim, T.S., Butler, N.S. and Perlman, S. (2004) Rapid and robust
infiltration of Ly6C hi monocytes into the CNS infected with a neurotropic
murine coronavirus. Submitted.
- Kim, T.S., Templeton, S. and Perlman, S. (2004) Both Complement and
Fc gamma Receptors Are Required for Antibody-Mediated Demyelination
in Mice infected with a Murine Coronavirus. J. of Immunol. Submitted.
- Kim, T.S., Perlman, S. (2003) Protection against
CTL escape and clinical disease in a murine model of virus persistence.
J. Immunol. 171:2006-2013.
- Ontiveros, E., Kim, T.S. and Perlman, S. (2003) Enhanced
Virulence Mediated by the Murine Coronavirus Mouse Hepatitis Virus,
strain JHM is associated with a Glycine at Amino Acid 310 of the Spike
Glycoprotein . J Virol. 77:10260-10269.
- Kim, T.S. and Perlman, S. (2003) The role of T cell epitopes
in coronavirus infection. In: Experimental Models of Multiple sclerosis.
E. Lavi, ed. (in press).
- Kirsch, J.D., Yi, A.K., Spitz, D.R., Krieg, A.M. (2002) Accumulation
of glutathione disulfide mediates NF-kappaB activation during immune
stimulation with CpG DNA.Antisense Nucleic Acid Drug Dev. Oct;12(5):327-40.
- Yi, A-K., Tuetken, R., Redford, T., Waldschmidt, M., Kirsch, J.,
and Krieg, A.M. (1998) CpG motifs in bacterial DNA activate leukocytes
through the pH-dependent generation of reactive oxygen species, J. Immunol.
160:4755-4761.
- Latinis, K., and Koretzky, G. (1996) Fas Ligation induces apoptosis
and Jun Kinase activation independently of CD45 and Lck in human T cells.
Blood 87:871-875.
- Latinis, K.M., Norian, L.A., Eliason, S.L., and Koretzky, G.A.
(1997) Two NFAT transcription factor binding sites participate in the
regulation of CD95 (Fas) ligand expression in activated human T cells.
J. Biol. Chem. 272:31427-31434.
- Latinis, K.M., Carr, L.L., Peterson, E.J., Norian, L.A.,
Eliason, S.L., and Koretzky, G.A. (1997) Regulation of CD95 (Fas) ligand
expression by TCR-mediated signaling events. J. Immunol. 158:4602-4611.
- Peterson, E.J., Latinis, K.M. and Koretzky, G.A. (1998) Molecular
characterization of a CD95 signaling mutant. Arthritis Rheum. 41:1047-1053.
- Faris, M., Kokot, N., Latinis, K., Kasibhatla, S., Green, D.R.,
Koretzky, G.A. and Nel, A. (1998) The c-Jun N-terminal kinase cascade
plays a role in stress-induced apoptosis in Jurkat cells by up-regulating
Fas ligand expression. J. Immunol. 160:134-144.
- Faris, M., Latinis, K.M., Kempiak, S.J., Koretzky, G.A. and
Nel, A. (1998) Stress-induced Fas ligand expression in T cells is mediated
through a MEK kinase 1-regulated response element in the Fas ligand
promoter. Mol. Cell. Biol. 18:5414-5424.
- Weiner, G.J., Liu, H., Wooldridge, J.E., Dahle, C.E. and Krieg,
A.M. (1997) Immunostimulatory oligodeoxynucleotides containing the CpG
motif are effective as immune adjuvants in tumor antigen immunization.
PNAS. 94:10833-10837.
- Liu, H., Newbrough, S.E., Bhatia, S., Dahle, C.E., Krieg, A.M.
and Weiner, G.J. (1998) Immunostimulatory CpG oligodeoxynucleotides
enhance the immune response to vaccine strategies involving GM-CSF.
Blood 92:3730-3736.
- Malik, Z.A., Thompson, C.R., Hashimi, S., Porter,
B., Iyer, S.S., Kusner, D.J. (2003) Cutting Edge: Mycobacterium tuberculosis
Blocks Ca(2+) Signaling and Phagosome Maturation in Human Macrophages
Via Specific Inhibition of Sphingosine Kinase. J Immunol. Mar 15;170(6):2811-5.
- Malik, Z.A., Denning, G., and Kusner, D.J. (2000) Inhibition
of Ca2+ signaling by mycobacterium tuberculosis is associated with
reduced
phagosome-lysosome fusion and increased survival within human macrophages.
J. Exp. Med. 191:287-302.
- Myung, P.S., Clements, J.L., White, D.W., Malik,
Z.A., Cowdery, J.S., Allen, L.H., Harty, J.T., Kusner, D.J., and
Koretzky, G.A. (2000) In vitro and in vivo macrophage function can occur
independently of SLP-76. Int. Immunol. 12:887-897.
- Malik, Z.A., Iyer, S.S., and Kusner, D.J. (2001) Mycobacterium
tuberculosis phagosomes exhibit altered calmodulin-dependent signal
transduction. Contribution to inhibition of phagosome-lysosome fusion
and intracellular survival in human macrophages. J. Immunol. 166:3392-3401.
- Hovis, R.R., Donovan, J.A., Musci, M.A., Motto, D.G., Goldman,
F.D., Ross, S.E., and Koretzky, G.A. (1993) Rescue of signaling by a
chimeric protein containing the cytoplasmic domain of CD45. Science
260:544-546.
- Motto, D.G., Musci, M.A., and Koretzky, G.A. (1994) Surface
expression of a heterologous phosphatase complements CD45 deficiency
in a T cell clone. J. Exp. Med. 180:1359-66.
- Motto, D.G., Musci, M.A., Ross, S.E., and Koretzky, G.A. (1996)
Tyrosine phosphorylation of Grb2-associated proteins correlates with
phospholipase Cg1 activation in T cells. Mol. Cell. Biol. 16:2823-2829.
- Musci, M. A., Latinis, K. M., and Koretzky, G. A. (1997) Signaling
events in T lymphocytes leading to cellular activation or programmed
cell death. Clin. Immunol. Immunopathol. 83:205-222.
- Musci, M.A., Beaves, S.L., Ross, S.E., Yi, T., and Koretzky,
G.A. (1997) Surface expression of hemopoietic cell phosphatases fails
to complement CD45 deficiency and inhibits TCR-mediated signal transduction
in a Jurkat T cell clone. J. Immunol. 158:1565-71.
- Musci, M.A., Motto, D.G., Ross, S.E., Fang, N. and Koretzky,
G.A. (1997) Three domains of SLP-76 are required for its optimal function
in a T cell line. J. Immunol. 159:1639-1647.
- Musci, M.A., Hendricks-Taylor, L.R., Motto, David G., Paskind,
M., Kamens, J., Turck, C.W., and Koretzky, G.A. (1997) Molecular cloning
of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated
protein tyrosine kinases. J. Biol. Chem. 272:11674-11677.
- Nanra, J.S., Takahashi, K., Tygrett, L.T., Wiechert,
S., Rennert, P.D. and Waldschmidt, T.J. (2003) Marginal zone maintenance
and optimal TI-2 antibody responses require cooperation between LTab
and TNFa.
(submitted).
- Nanra, J.S., Takahashi, K., Tygrett, L.T., Wiechert, S.C., Rennert,
P.D., and Waldschmidt, T.J. (2004) Marginal zone maintenance and optimal
TI-2 antibody responses require cooperation between LT alpha beta and
TNF alpha. Submitted.
- Norian, L.A., Latinis, K.M., Eliason, S.L., Lyson, K.,
Yang, C., Ratliff, T., and Koretzky, G.A. (2000) The regulation of CD95
(Fas) ligand expression in primary T cells: induction of promoter activation
in CD95LP-Luc transgenic mice.
J. Immunol.164(9):4471-4480.
- Norian, L.A., and Koretzky, G.A. (2000) Intracellular adapter
molecules. Semin. Immunol. 12:43-54. Review.
- Norian, L.A., Latinis, K.M., and Koretzky, G.A. (1998) A newly
identified response element in the CD95 (Fas) ligand promoter contributes
to optimal inducibility in activated T lymphocytes. J. Immunol. 161:1078-1082.
- Cowdery, J.S., Boerth, N.J., Norian, L.A., Myung, P.S., and
Koretzky, G.A. (1999) Differential regulation of the IL-12 p40 promoter
and of p40 secretion by CpG DNA and lipopolysaccharide. J. Immunol.
162:6770-6775.
- Norian, L.A., and Koretzky, G.A. (1999) TCR-induced signaling
for cytotoxicity: The regulation of CD95L (Fas Ligand) expression
in
activated T lymphocytes, In "Cytotoxic Cells: Basic Mechanisms and
Medical Applications", Editors: Ditovsky, M.V. And Henkart, P.A.,
Publisher, Lippincott-Raven, in press.
- Ontiveros, E., Kim, T.S., Gallagher,
T.M., Perlman, S. (2003) Enhanced virulence mediated by the murine
coronavirus, mouse hepatitis virus strain JHM, is associated with a
glycine at residue
310 of the spike glycoprotein. J. Virol. 77:10260-10269.
- Ontiveros, E., Kuo, L., Masters, P.S., and Perlman, S. (2001)
Inactivation of Expression of Gene 4 of Mouse Hepatitis Virus Strain
JHM Does Not Affect Virulence in the Murine CNS. Virology. 289(2): 230-238.
- Ontiveros, E., Kuo, L., Masters, P., and Perlman, S. (2001)
Analysis of nonessential gene function in recombinant MHV-JHM. Gene
4 knockout recombinant virus. Adv. Exp. Med. Biol. 494:83-9.
- Badovinac, V. P., Porter, B.B. and Harty, J.T. (2004) CD8+ T cell
contraction is controlled by early inflammation Published online: 11
July 2004 | doi:10.1038/ni1098.
-
Badovinac, V.P., Porter, B.B., Harty, J.T. (2002) Programmed
contraction of CD8(+) T cells after infection. Nat. Immunol. 7:619-26.
- Li, Y.-Y., Smith, K.D., Shi, Y., and Lutz, C.T. (1996) Alloreactive
anti-HLA-B7 cytolytic T cell clones use restricted T cell receptor genes.
Transplantation 62:954-961.
- Shi, Y., Smith, K.D., Kurilla, M.G., and Lutz, C.T. (1997)
Cytotoxic CD8+ T cells recognize EBV antigen but poorly kill autologous
EBV-infected B lymphoblasts. J. Immunol. 159:1844-1852.
- Shi, Y., K.D. Smith, and Lutz, C.T. (1998) TAP-independent
MHC class I peptide antigen presentation to alloreactive CTL is enhanced
by target cell incubation at subphysiologic temperatures. J. Immunol
160:4305-4312.
- Shi, Y., and Lutz, C.T. (2002) Interferon-g
control of EBV-transformed B cells. A role for CD8+ T cells that poorly
kill EBV-infected cells. Viral Immunol. 15:213-225.
- Shinall, S.M., Wolniak, K.L., Cozine, C., Dandekar, A.A., Perlman,
S., and Waldschmidt, T.J. (2004) Antigen- and Stain- Independent
Characteristics of the Primary Germinal Center Reaction in Mice.
Submitted.
- Shinall, S.M., Gonzalez-Fernandez, M., Noelle, R.J., Waldschmidt,
T.J. (2000) Identification of murine germinal center B cell subsets
defined by the expression of surface isotypes and differentiation
antigens. J. Immunol. 164:5729-5738.
- Takahashi, K., Kozono, Y., Waldschmidt, T., Berthiaume, D.,
Quigg, R.J., Baron, A., and Holers, V.M. (1997) Mouse complement receptors
Type 1 (CR1, CD35) and 2 (CR2, CD21): Expression on normal B cell subpopulations
and decreased levels during the development of autoimmunity in MRL/1pr
mice. J. Immunol. 159:1557-1569.
-
Griffith, T.S., Kawakita, M., Tian, J., Ritchey, J., Tartaglia,
J., Sehgal, I., Thompson, T.C., Zhao, W., Ratliff, T.L. (2001) Inhibition
of murine prostate tumor growth and activation of immunoregulatory
cells with recombinant canarypox viruses. J. Natl. Cancer Inst.
93:998-1007.
- Elzey, B.D., Tian, J., Jensen, R.J., Swanson, A.K., Lees,
J.R.,
Lentz, S.R., Stein, C.S., Nieswandt, B., Wang, Y., Davidson, B.L.,
Ratliff, T.L. Platelet-mediated modulation of adaptive immunity.
A communication link between
innate and adaptive immune compartments.
Immunity. 2003 1:9-19.
- VanOosten, R.L., Moore, J.M., Ludwig, A., and Griffith, T.S. (2004)
Depsipeptide (FR901228) enhances the cytotoxic activity of TRAIL by
increasing the levels of TRAIL receptor within membrane lipid rafts.
Submitted.
- White, D.W., Wilson, R.L., and Harty, J.T. (1996) CD8+ Tcells
in intracellular bacterial infections in mice. Res. Immunol. 147:519-524.
- White, D. W. and Harty, J.T. (1998) Perforin-deficient CD8+
T cells provide immunity to Listeria monocytogenes by a mechanism which
is independent of CD95 and IFNg but requires
TNFa. J. Immunol. 160:898-905.
- White, D. W. , MacNeil, A., Busch, D.H., Pilip, I.M. , Pamer,
E.G. and Harty, J.T. (1999) Perforin-deficient CD8+ T cells in vivo:
priming and antigen specific immunity against Listieria monocytogenes.
J. Immunol. 162:980-988.
- White, D. W., Badovinac, V.P., Fan, X. and Harty, J.T. (2000)
Adaptive immunity against Listeria monocytogenes in the absence of type
I tumor necrosis factor receptor p55. Infect. Immun. 68: 4470-4476.
- White, D. W., Badovinac, V.P., Kollias, G. and Harty, J.T.
(2000) Cutting Edge: Antilisterial activity of CD8+ T cell derived From
TNF-deficient and TNF/perforin double-deficient mice. J. Immunol. 165:5-9.
- Harty, J.T., Tvinnereim, A.R., and White, D.W.(2000) CD8+ T
cell effector mechanisms in resistance to infection. Annu. Rev. Immunol.
18:275-308. Review.
- Wilson, R.L., White, D.W., and Harty, J.T. (2000) Transient
expression of bacterial gene fragments in eukaryotic cells:
implications for CD8(+) T cell epitope analysis. J. Immunol. Methods.
234:137-47.
- Harty, J.T., and White, D. (1999) A knockout approach to understanding
CD8+ cell effector mechanisms in adaptive
immunity to Listeria monocytogenes. Immunobiology. 201:196-204.
Review.
- Wolniak, K.L., Shinall, S.M., and Waldschmidt, T.J. (2004) The primary
germinal center response. Crit. Rev. Immunol. 24:39-66.
- Wolniak, K.L., Noelle, R.J., Shlomchik, M.J., and Waldschmidt,
T.J. (2004) Flow cytometric analysis of the primary (4-hydroxy-3-nitrophenyl)acetyl
specific B cell response in mice. Characterization of antigen-binding
B220+ germinal center and B220- splenic populations. Submitted.
- Zhao, L., Shey, M., Farnsworth, M., Dailey, M.O. (2001) Regulation
of membrane metalloproteolytic cleavage of L-selectin (CD62l) by the
epidermal growth factor domain. J. Biol. Chem. Aug 17;276(33):30631-40.
- Zhao, L., Edgar, J., and Dailey, M.O. (2001) Characterization
of the rapid proteolytic shedding of murine L-selectin. Dev. Immunol.
8(3-4):267-77.
|